blog

Industry insights from our own scientists, publicists, developers, designers, strategists and more.

Our experts have spent their careers learning their craft, honing their skills and implementing the most effective marketing, engagement and public relations strategies to help healthcare and science brands transform the world. Let's dive in, shall we?

Other insights

NIH Budget Cuts: A Threat to Scientific Progress

Proposed cuts to the National Institutes of Health (NIH) budget—including a sharp reduction in indirect cost reimbursements—threaten to destabilize the very foundation of biomedical research in the United States.

Dillon Allie | February 13, 2025

Biotech | Life Sciences | Current Affairs

Trump, China’s Rise and The Forces Shaping Biotech’s Future

This year, the industry was rocked by the aftermath of UnitedHealthcare CEO Brian Thompson’s tragic murder last December, which led 11 major health insurance companies to quietly withdraw from JPM last week. Heightened security, bomb-sniffing dogs, and a palpable sense of caution surrounded Union Square. Thankfully, the conference, itself, concluded without incident.

John Kang | January 21, 2025

Conferences & Events | Biotech | Current Affairs

JPM 2025 Preview: Five Key Trends HDMZ Will Be Watching in Biotech

It’s the most wonderful time of the year for biotech and the broader life sciences industry — the J.P. Morgan (JPM) Healthcare Conference 2025 is just around the corner.

John Kang | January 06, 2025

Conferences & Events | Biotech

Halfway through 2024, cautious optimists have reason to celebrate

BIO 2024 serves a mid-year barometer for how the life sciences industry is faring, and so far, the industry has responded with excitement.

Azeem Zeekrya, Director, Public Relations | June 17, 2024

AI in biotech is leading to unimagined approaches to improving human health

The power of AI is finally starting to show promise for improving human health. Learn about some of the most innovative AI-based companies HDMZ is watching in the biotech sector.

Joe Salerno, Vice President, Scientific Communications | May 23, 2024

AI | Biotech | HDMZ | Machine learning

Small Molecules are Exciting Again with AI’s Help

Our experts have been closely watching the AI gold rush in biotech and think that it will lead to a boom in small molecule drug development.

Azeem Zeekrya, Director, Public Relations | March 27, 2024

Biotech Moves Forward With Cautious Optimism

HDMZ’s in-depth analysis of the 2024 J.P. Morgan Healthcare Conference unveils trends — including pharma headwinds, AI and Wegovy — that will shape the life science industry this year.

John Kang, Senior Vice President, Public Relations | January 16, 2024

AI | Biotech | Conferences & Events

Chicago, Chicago, That Biotech Town

Last month, a Chicago-based biotech company called CellTrans was on the receiving end of a remarkable regulatory milestone: The company received FDA approval for the first cellular therapy for Type-1 diabetes.

Dillon Allie, President & CEO | July 19, 2023

Biotech | Life Sciences

With Major Government Support, Biotech and Life Sciences Likely Heading Into Innovation Renaissance

Read this week’s blog post to see how Biden’s new executive order may spark biotech, healthcare and life sciences innovations and startups.

Azeem Zeekrya, Associate Director, Scientific Communications | October 24, 2022

Biotech | Life Sciences | Current Affairs

Zoomedia & Harris D. McKinney Join Forces

For the last 16 years, Zoomedia has been leading interactive communications for the life sciences. Today, we are delighted to announce that we have joined forces with Harris D. McKinney, a leading life science marketing and brand communications agency.

Barbara Lavery | June 11, 2014